Iron
Iron Chelating Agents
Iron Overload
An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989)
Iron, Dietary
Iron Isotopes
Iron Radioisotopes
Ferritins
Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types.
Iron Compounds
Anemia, Iron-Deficiency
Transferrin
Iron Regulatory Protein 1
A multifunctional iron-sulfur protein that is both an iron regulatory protein and cytoplasmic form of aconitate hydratase. It binds to iron regulatory elements found on mRNAs involved in iron metabolism and regulates their translation. Its RNA binding ability and its aconitate hydrolase activity are dependent upon availability of IRON.
Iron Metabolism Disorders
Iron Regulatory Protein 2
Deferoxamine
Siderophores
Receptors, Transferrin
Hepcidins
Forms of hepcidin, a cationic amphipathic peptide synthesized in the liver as a prepropeptide which is first processed into prohepcidin and then into the biologically active hepcidin forms, including in human the 20-, 22-, and 25-amino acid residue peptide forms. Hepcidin acts as a homeostatic regulators of iron metabolism and also possesses antimicrobial activity.
Iron-Dextran Complex
Anemia, Hypochromic
Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)
Hemochromatosis
A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)
Nonheme Iron Proteins
Hemoglobins
Cation Transport Proteins
Iron-Regulatory Proteins
Apoferritins
The protein components of ferritins. Apoferritins are shell-like structures containing nanocavities and ferroxidase activities. Apoferritin shells are composed of 24 subunits, heteropolymers in vertebrates and homopolymers in bacteria. In vertebrates, there are two types of subunits, light chain and heavy chain. The heavy chain contains the ferroxidase activity.
Heme
Antimicrobial Cationic Peptides
Small cationic peptides that are an important component, in most species, of early innate and induced defenses against invading microbes. In animals they are found on mucosal surfaces, within phagocytic granules, and on the surface of the body. They are also found in insects and plants. Among others, this group includes the DEFENSINS, protegrins, tachyplesins, and thionins. They displace DIVALENT CATIONS from phosphate groups of MEMBRANE LIPIDS leading to disruption of the membrane.
Glucaric Acid
FMN Reductase
Chelation Therapy
Ferrozine
beta-Thalassemia
A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent.
Iron-Sulfur Proteins
Biological Availability
Food, Fortified
Any food that has been supplemented with essential nutrients either in quantities that are greater than those present normally, or which are not present in the food normally. Fortified food includes also food to which various nutrients have been added to compensate for those removed by refinement or processing. (From Segen, Dictionary of Modern Medicine, 1992)
Magnetite Nanoparticles
Siderosis
Phlebotomy
Absorption
Homeostasis
Erythrocyte Indices
Zinc
A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.
Oxidation-Reduction
A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471).
Nitrilotriacetic Acid
Ferrosoferric Oxide
Aconitate Hydratase
Copper
Liver
Spectroscopy, Mossbauer
A spectroscopic technique which uses the Mossbauer effect (inelastic scattering of gamma radiation resulting from interaction with heavy nuclei) to monitor the small variations in the interaction between an atomic nucleus and its environment. Such variations may be induced by changes in temperature, pressure, chemical state, molecular conformation, molecular interaction, or physical site. It is particularly useful for studies of structure-activity relationship in metalloproteins, mobility of heavy metals, and the state of whole tissue and cell membranes.
Enterobactin
Hematocrit
Dietary Supplements
Products in capsule, tablet or liquid form that provide dietary ingredients, and that are intended to be taken by mouth to increase the intake of nutrients. Dietary supplements can include macronutrients, such as proteins, carbohydrates, and fats; and/or MICRONUTRIENTS, such as VITAMINS; MINERALS; and PHYTOCHEMICALS.
Protoporphyrins
Hemosiderosis
Ascorbic Acid
A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.
Phytic Acid
Lactoferrin
An iron-binding protein that was originally characterized as a milk protein. It is widely distributed in secretory fluids and is found in the neutrophilic granules of LEUKOCYTES. The N-terminal part of lactoferrin possesses a serine protease which functions to inactivate the TYPE III SECRETION SYSTEM used by bacteria to export virulence proteins for host cell invasion.
Electron Spin Resonance Spectroscopy
A technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons. The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. (From McGraw-Hill Encyclopedia of Science and Technology, 7th edition) Electron nuclear double resonance (ENDOR) spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications such as MAGNETIC RESONANCE IMAGING.
Biological Transport
Duodenum
Hematinics
Bloodletting
Erythropoiesis
The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction.
Ferrichrome
Trace Elements
Oxidative Stress
Deficiency Diseases
Membrane Proteins
Pregnancy Complications, Hematologic
Thalassemia
Molecular Sequence Data
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Chelating Agents
Gene Expression Regulation, Bacterial
Erythropoietin
Edetic Acid
Benzoates
Manganese
A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)
Hemin
Mutation
Hemeproteins
Citric Acid
Micronutrients
Histocompatibility Antigens Class I
Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells.
Transferrin-Binding Proteins
Blood Transfusion
Spectrophotometry, Atomic
Apoproteins
Mononuclear Phagocyte System
Mononuclear cells with pronounced phagocytic ability that are distributed extensively in lymphoid and other organs. It includes MACROPHAGES and their precursors; PHAGOCYTES; KUPFFER CELLS; HISTIOCYTES; DENDRITIC CELLS; LANGERHANS CELLS; and MICROGLIA. The term mononuclear phagocyte system has replaced the former reticuloendothelial system, which also included less active phagocytic cells such as fibroblasts and endothelial cells. (From Illustrated Dictionary of Immunology, 2d ed.)
Erythrocytes
Dextrans
Oxidoreductases
The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9)
Spectrum Analysis
Metalloproteins
Sulfur
Porphyrins
A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.
Oxygen
Hydrogen-Ion Concentration
Infant Food
Amino Acid Sequence
Cloning and characterization of a maize cytochrome-b5 reductase with Fe3+-chelate reduction capability. (1/1144)
We previously purified an NADH-dependent Fe3+-chelate reductase (NFR) from maize roots with biochemical features of a cytochrome-b5 reductase (b5R) [Sparla, Bagnaresi, Scagliarini and Trost (1997) FEBS Lett. 414, 571-575]. We have now cloned a maize root cDNA that, on the basis of sequence information, calculated parameters and functional assay, codes for NFR. Maize NFR has 66% and 65% similarity to mammal and yeast b5R respectively. It has a deduced molecular mass of 31.17 kDa and a pI of 8.53. An uncharged region is observed at its N-terminus but no myristoylation consensus site is present. Taken together, these results, coupled with previous biochemical evidence, prove that NFR belongs to the b5R class and document b5R from a plant at the molecular level for the first time. We have also identified a putative Arabidopsis thaliana NFR gene. Its organization (nine exons) closely resembles mammalian b5Rs. Several NFR isoforms are expected to exist in maize. They are probably not produced by alternative translational mechanisms as occur in mammals, because of specific constraints observed in the maize NFR cDNA sequence. In contrast with yeast and mammals, tissue-specific and various subcellular localizations of maize b5R isoforms could result from differential expression of the various members of a multigene family. The first molecular characterization of a plant b5R indicates an overall remarkable evolutionary conservation for these versatile reductase systems. In addition, the well-characterized Fe3+-chelate reduction capabilities of NFR, in addition to known Fe3+-haemoglobin reduction roles for mammal b5R isoforms, suggest further and more generalized roles for the b5R class in endocellular iron reduction. (+info)Down regulation by iron of prostaglandin E2 production by human synovial fibroblasts. (2/1144)
OBJECTIVE: To examine the effect of iron on the prostaglandin (PG) E2 production by human synovial fibroblasts in vitro. METHODS: Human synovial fibroblasts were isolated from synovial tissue of rheumatoid arthritis (RA) and osteoarthritis (OA) patients and cultured in medium. Synovial fibroblasts were stimulated by human recombinant interleukin (IL) 1 beta (0.1-10 ng/ml) with or without ferric citrate (Fe-citrate, 0.01-1 mM). The amount of PGE2 in the culture medium was measured by an enzyme linked immunosorbent assay. RESULTS: The production of PGE2 by the synovial fibroblasts was increased by stimulation with IL1 beta at all concentrations tested. Fe-citrate but not sodium citrate (Na-citrate) down regulated the production of PGE2 by the synovial fibroblasts, both with and without stimulation by IL1 beta. Fe-citrate inhibited the spontaneous PGE2 production by the cells in a dose dependent manner, and a maximum inhibition by Fe-citrate was observed at the concentration of 0.1 mM with IL1 beta stimulation. The down regulation by iron was reversed by the co-addition of desferrioxamine (100 micrograms/ml), an iron chelator. CONCLUSION: Iron down regulates the PGE2 production by synovial fibroblasts in vitro. (+info)Salmonella typhimurium encodes a putative iron transport system within the centisome 63 pathogenicity island. (3/1144)
Upon entry into the host, Salmonella enterica strains are presumed to encounter an iron-restricted environment. Consequently, these bacteria have evolved a variety of often-redundant high-affinity acquisition systems to obtain iron in this restricted environment. We have identified an iron transport system that is encoded within the centisome 63 pathogenicity island of Salmonella typhimurium. The nucleotide composition of this locus is significantly different from that of the rest of this pathogenicity island, suggesting a different ancestry and a mosaic structure for this region of the S. typhimurium chromosome. This locus, designated sit, consists of four open reading frames which encode polypeptides with extensive homology to the yfe ABC iron transport system of Yersinia pestis, as well as other ABC transporters. The sitA gene encodes a putative periplasmic binding protein, sitB encodes an ATP-binding protein, and sitC and sitD encode two putative permeases (integral membrane proteins). This operon is capable of complementing the growth defect of the enterobactin-deficient Escherichia coli strain SAB11 in iron-restricted minimal medium. Transcription of the sit operon is repressed under iron-rich growth conditions in a fur-dependent manner. Introduction of a sitBCD deletion into wild-type S. typhimurium resulted in no apparent growth defect in either nutrient-rich or minimal medium and no measurable virulence phenotype. These results further support the existence of redundant iron uptake systems in S. enterica. (+info)Characterization of exochelins of the Mycobacterium bovis type strain and BCG substrains. (4/1144)
Pathogenic mycobacteria must acquire iron in the host in order to multiply and cause disease. To do so, they release abundant quantities of siderophores called exochelins, which have the capacity to scavenge iron from host iron-binding proteins and deliver it to the mycobacteria. In this study, we have characterized the exochelins of Mycobacterium bovis, the causative agent of bovine and occasionally of human tuberculosis, and the highly attenuated descendant of M. bovis, bacillus Calmette-Guerin (BCG), widely used as a vaccine against human tuberculosis. The M. bovis type strain, five substrains of M. bovis BCG (Copenhagen, Glaxo, Japanese, Pasteur, and Tice), and two strains of virulent Mycobacterium tuberculosis all produce the same set of exochelins, although the relative amounts of individual exochelins may differ. Among these mycobacteria, the total amount of exochelins produced is greatest in M. tuberculosis, intermediate in M. bovis, and smallest in M. bovis BCG. (+info)Ferrioxamine-mediated Iron(III) utilization by Salmonella enterica. (5/1144)
Utilization of ferrioxamines as sole sources of iron distinguishes Salmonella enterica serotypes Typhimurium and Enteritidis from a number of related species, including Escherichia coli. Ferrioxamine supplements have therefore been used in preenrichment and selection media to increase the bacterial growth rate while selectivity is maintained. We characterized the determinants involved in utilization of ferrioxamines B, E, and G by S. enterica serotype Typhimurium by performing siderophore cross-feeding bioassays. Transport of all three ferric siderophores across the outer membrane was dependent on the FoxA receptor encoded by the Fur-repressible foxA gene. However, only the transport of ferrioxamine G was dependent on the energy-transducing protein TonB, since growth stimulation of a tonB strain by ferrioxamines B and E was observed, albeit at lower efficiencies than in the parental strain. Transport across the inner membrane was dependent on the periplasmic binding protein-dependent ABC transporter complex comprising FhuBCD, as has been reported for other hydroxamate siderophores of enteric bacteria. The distribution of the foxA gene in the genus Salmonella, as indicated by DNA hybridization studies and correlated with the ability to utilize ferrioxamine E, was restricted to subspecies I, II, and IIIb, and this gene was absent from subspecies IIIa, IV, VI, and VII (formerly subspecies IV) and Salmonella bongori (formerly subspecies V). S. enterica serotype Typhimurium mutants with either a transposon insertion or a defined nonpolar frameshift (+2) mutation in the foxA gene were not able to utilize any of the three ferrioxamines tested. A strain carrying the nonpolar foxA mutation exhibited a significantly reduced ability to colonize rabbit ileal loops compared to the foxA+ parent. In addition, a foxA mutant was markedly attenuated in mice inoculated by either the intragastric or intravenous route. Mice inoculated with the foxA mutant were protected against subsequent challenge by the foxA+ parent strain. (+info)Role of free radicals in the pathogenesis of lipid-induced glomerulosclerosis in rats. (6/1144)
BACKGROUND: We examined whether a high-cholesterol (HC) diet causes glomerulosclerosis in rats, and investigated the role of free radicals and lipid peroxidation in lipid-induced glomerulosclerosis. METHODS: The rats were given a normal diet, a HC diet, or a HC diet with antioxidants and radical scavengers. Serum levels of lipid, lipid peroxide (LOOH), urinary excretion of protein (UP), and urinary norepinephrine excretion (UNE) were measured. The glomerular sclerosing score was used to evaluate the renal injury. RESULTS: Blood pressure, total cholesterol, and LOOH were increased by a HC diet, as were UP and UNE. The HC diet induced renal injury. Treatment with superoxide dismutase, dimetylthiourea as a scavenger of hydroxyl radical (OH.), defferoxamine masilate as an iron chelator, or vitamin E inhibited the increases in blood pressure, LOOH, UP, and UNE, whereas total cholesterol was not affected. The production of superoxide anion (O2-.) by neutrophil and LOOH in the kidney was increased, and superoxide dismutase and hydrogen peroxide in the kidney were decreased. Almost all of these changes were attenuated by vitamin E; however, the O2-. production was not inhibited. OH. was increased by the HC diet, and it was normalized with the treatments. Furthermore, the sclerosing score was partially suppressed by the treatments. Ferric iron was stained in the proximal tubulus, and it was not observed in the treated rats. CONCLUSIONS: The data suggest that lipid peroxidation is involved in the pathogenesis of lipid-induced glomerulosclerosis and that O2-. and OH. may play a role in the process. (+info)The haemin storage (Hms+) phenotype of Yersinia pestis is not essential for the pathogenesis of bubonic plague in mammals. (7/1144)
The haemin storage (Hms+) phenotype of Yersinia pestis enables this bacillus to form greenish/brown or red colonies on haemin or Congo Red agar plates, respectively, at 26 but not 37 degrees C. Escherichia coli strains that contain mutations in genes essential for siderophore biosynthesis, porphyrin generation and/or haemin transport remain unable to utilize exogenous haemin as a nutritional iron or porphyrin source when transformed with the cloned Y. pestis hmsHFRS locus. Further physiological analysis of the Hms+ phenotype of Y. pestis strain KIM6+ suggests that the haemin and inorganic iron stored by the Hms system was not used nutritionally under subsequent iron-deficient conditions. In vitro analysis of the bactericidal effects of hydrogen peroxide, superoxide and nitric oxide showed that Hms- Y. pestis cells, in certain cases, were more susceptible than the Hms+ parent cells to these reactive oxygen species at 26 and/or 37 degrees C. In adherence assays, a higher percentage of Hms+ cells were associated with HeLa cells and normal human neutrophils, compared to Hms- cells. However, the Hms+ phenotype did not provide any additional protection against the killing effects of neutrophils. Finally, LD50 analysis in subcutaneously infected mice showed that an Hms- strain was slightly more virulent than Hms+, indicating that the Hms phenotype is not essential for the pathogenesis of bubonic plague in mammals. (+info)Iron dependence of tryptophan hydroxylase activity in RBL2H3 cells and its manipulation by chelators. (8/1144)
Tryptophan hydroxylase requires Fe2+ for in vitro enzyme activity. In this study, the intracellular activity of tryptophan hydroxylase was assessed by applying 3-hydroxybenzylhydrazine (NSD-1015), an inhibitor of aromatic l-amino acid decarboxylase, to monolayer cultures of RBL2H3 cells, a serotonin producing mast cell line. The effect of manipulating intracellular 'free' iron levels on enzyme activity was analyzed by administration of iron chelators. Desferrioxamine (DFO) suppressed the intracellular enzyme activity. Salicylaldehyde isonicotinoyl hydrazone (SIH) also suppressed enzyme activity, but stimulated it when administered in the Fe-bound form. Hemin also stimulated enzyme activity, which progressively increased over several hours to more than sixfold the initial level. DFO and SIH inhibited the hemin stimulatory effect when administered simultaneously with hemin. Both suppression and stimulation with these chelators took place without a significant decrease or increase in the amount of enzyme. These results indicate that there was an inadequate supply of Fe2+ in the cells to support full activity of tryptophan hydroxylase. (+info)
Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded...
Deferasirox for managing iron overload in people with thalassaemia | Cochrane
Remove iron from agar? - Microbiology
Deferasirox - Side Effects, Uses, Dosage, Overdose, Pregnancy, Alcohol | RxWiki
Plus it
Deferasirox Side Effects: Common, Severe, Long Term - Drugs.com
Find Deferasirox (90mg) alternatives online at lowest price in India - PillsBills.com
FDA And Novartis Announce A Label Change For Iron Chelating Drug Exjade In Mid-February 2010 | Thomas J. Lamb - JDSupra
Expected outcomes of Fair Park II - Fair Park II (fairpark2.eu)
EXJADE - Drugs.com
A multi-center, randomized, double-blind, placebo-controlled clinical
trial of deferasirox in patients with myelodysplastic...
4,5-dihydro-2-(2-hydroxy-4-(12-amino-5,9-diazadodecyloxy)phenyl)-4-methyl-4-thiazolecarboxylic acid
Summary Report |...
Chelators: list of medications for children and adults
Deferasirox (Exjade®) significantly improves cardiac T2* in heavily iron-overloaded patients with β-thalassemia major<...
Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia
Early cardiac iron overload in children with transfusion-dependent anemias | Haematologica
Oral deferiprone for iron chelation in people with thalassaemia. - Radcliffe Department of Medicine
Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk...
An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670)in β-thalassemia Patients With Transfusional Iron...
The Oral Iron Chelator Deferiprone Protects Against Retinal Degeneration Induced through Diverse Mechanisms | TVST | ARVO...
Iron chelation therapy in myelodysplastic syndromes: where do we stand? | Aplastic Anemia and MDS International Foundation
Most recent papers with the keyword Functional MRI | Read by QxMD
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia. - Radcliffe...
Iron chelators as therapeutic agents against Pneumocystis carinii. | Antimicrobial Agents and Chemotherapy
NCCN Task Force: Transfusion and Iron Overload in Patients With Myelodysplastic Syndromes in: Journal of the National...
NCCN Task Force: Transfusion and Iron Overload in Patients With Myelodysplastic Syndromes in: Journal of the National...
The Influence of Iron Loading and Iron Chelation on the Proliferation and Telomerase Activity of Human Peripheral Blood...
Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron...
Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron...
FDA approves expanded use for Chiesis sickle cell drug Ferriprox - PMLiVE
Deferiprone - Wikipedia
Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream...
Indian Patents. 222753:2-PYRIDYLCARBOXALDEHYDE ISOMCOTINOYL HYDRAZONE AS IRON CHELATORS.
USE OF DEFERASIROX (EXJADE) FOR IRON OVERLOAD IN PERITONEAL DIALYSIS PATIENTS. | 54th ANZSN ASM 2018
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
Deferiprone Brands In India - World Trust Pharmacy
Biochemical study of Labile Plasma Iron (LPI) measurement in serum or plasma (Aferrix kit) (Code 90020) - BloodGenetics
Iron Chelation Therapy Treats Iron Overload in MDS | PracticeUpdate
Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia - AdisInsight
Deferasirox may revolutionize the way chronic iron overload is treated
Why Chelation Therapy
JARS v58n1 - Tips for Beginners: Chelated Fertilizers
Iron and Dietary Supplements
Iron: an essential mineral for blood production - nourish me
Molecular mechanisms and regulation of iron transport<...
Toxicity Associated with Iron - Renal and Urology News
Active Iron Supplements | Ferrous Sulfate Iron Capsules
Discussing deferasirox always take into consideration deferasirox
Deferasirox CAS#: 201530-41-8
Chelation Therapy - Benefits - Side Effects - Health Tips
Regulation of iron uptake in primary culture rat hepatocytes: the role of acute-phase cytokines. | MRC Centre for Regenerative...
Iron (Fe) | Osnovyanka- osnovyanka.com.ua
Iron (Fe) Test Urologic Physicians and Surgeons
10 Best Iron Supplements 2018: Benefits, Side Effects & Dosage Info - Best Reviews ,Tests in 2020 Brands
Expatriate Insurance News: Iron-chelating drug could disrupt Alzheimers
Malaria
There is insufficient evidence that iron chelating agents such as deferoxamine and deferiprone improve outcomes of those with ... Cochrane Infectious Diseases Group) (2003-04-22). "Iron chelating agents for treating malaria". The Cochrane Database of ... There is insufficient data on whether osmotic agents such as mannitol or urea are effective in treating cerebral malaria. ... Biot C, Castro W, Botté CY, Navarro M (2012). "The therapeutic potential of metal-based antimalarial agents: Implications for ...
Podsolisation
In podsolisation, chelating agents break down clay and release minerals such as iron and aluminium. When iron and aluminium are ... These organic acids are known as chelating agents. Many podsol soils form underneath coniferous forests, the fact that pine ... As a result an acidic (pH 4.5) mor humus is produced which provides a greater amount of chelating agents. ... In many podsols, Iron Pans are created. This can cause water logging which may then saturate the A horizon leading to mottling ...
Ionophore
Iron ionophores and chelating agents are collectively called siderophores. Many synthetic ionophores are based on crown ethers ... It also serves as an anti-fouling agent in paints to cover and protect surfaces against mildew and algae. Clioquinol and PBT2 ... It is also used as a food additive, shelf-life extending agent in food packaging, and wood preservative in timber treatment. ... "Chapter 76:Antifungal Agents". Medical microbiology (4th ed.). Galveston, Tex.: University of Texas Medical Branch at Galveston ...
Chelation
These ligands are called chelants, chelators, chelating agents, or sequestering agents. They are usually organic compounds, but ... Chelate complexes of gadolinium are often used as contrast agents in MRI scans, although iron particle and manganese chelate ... Chelating agents convert these metal ions into a chemically and biochemically inert form that can be excreted. Chelation using ... Such chelating agents include the porphyrin rings in hemoglobin and chlorophyll. Many microbial species produce water-soluble ...
Aerobactin
... is a bacterial iron chelating agent (siderophore) found in E. coli. It is a virulence factor enabling E. coli to ... sequester iron in iron-poor environments such as the urinary tract. Aerobactin is biosynthesized by the oxidation of lysine, ... Cianciotto NP (June 2007). "Iron acquisition by Legionella pneumophila". Biometals. 20 (3-4): 323-31. doi:10.1007/s10534-006- ... Structure and Function of Microbial Iron Transport Compounds". J. Biol. Chem. 270 (45): 26723-26726. doi:10.1074/jbc.270.45. ...
Transfusion hemosiderosis
This involves delivering iron chelating agents such as deferoxamine, deferiprone or deferasirox. If iron overload has caused ... Hemoglobin, the oxygen-carrying molecule in a red blood cell, contains iron. The body has limited ways to store and remove iron ... Transfusional hemosiderosis is the accumulation of iron in the body due to frequent blood transfusions. Iron accumulates in the ... Lu JP, Hayashi K (1994). "Selective iron deposition in pancreatic islet B cells of transfusional iron-overloaded autopsy cases ...
Sideroblastic anemia
... a chelating agent, is used to treat iron overload from transfusions. Therapeutic phlebotomy can be used to manage iron overload ... Serum iron, percentage saturation and ferritin are increased. The total iron-binding capacity of the cells is normal to ... Serum Iron: high increased ferritin levels decreased total iron-binding capacity high transferrin saturation Hematocrit of ... To count a cell as a ring sideroblast, the ring must encircle a third or more of the nucleus and contain five or more iron ...
Iron(III) phosphate
Pesticide pellets contain iron phosphate plus a chelating agent, such as EDTA. The Research Institute of Organic Agriculture ( ... the lower phosphate of iron Lithium iron phosphate battery, a battery that uses iron phosphate Phosphate conversion coating, an ... Iron(III) phosphate can be used in steel and metal manufacturing processes. When bonded to a metal surface, iron phosphate ... Sigma-Aldrich Co., Iron(III) phosphate dihydrate. Retrieved on 2014-05-03. "Iron(III) Phosphate". NIH, U.S. National Library of ...
Chelation therapy
The chelating agent may be administered intravenously, intramuscularly, or orally, depending on the agent and the type of ... Since the 1970s, iron chelation therapy has been used as an alternative to regular phlebotomy to treat excess iron stores in ... Other chelating agents have been discovered. They all function by making several chemical bonds with metal ions, thus rendering ... Other chelating agents, such as 2,3-dimercaptopropanesulfonic acid (DMPS) and alpha lipoic acid (ALA), are used in conventional ...
Management of thalassemia
Deferoxamine, deferiprone and deferasirox are the three most widely used iron-chelating agents.[citation needed] The drug ... and it also decreases the uptake of iron by tissues. Deferoxamine achieves this by acting as a hexadentate iron-chelating ... This reduction in height may occur as a result of deferoxamine chelating metals other than iron which are required for normal ... 2006-01-01). "Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with β- ...
Hinokitiol
It is considered as a broad-spectrum metallophore, and an efficient iron-chelating agent. The iron complex with hinokitiol with ... Due to its iron-chelating activity, hinokitiol has been called an "Iron Man molecule" in the scientific media, which is ironic ... Chelating agents, Skin care, Oral hygiene, Food additives, Preservatives). ... Due to the latter effects, hinokitiol is used in food packaging as a shelf-life extending agent. Hinokitiol is one of the ...
Iron(III) oxide
It also dissolves well in solutions of chelating agents such as EDTA and oxalic acid. Heating iron(III) oxides with other metal ... It is one of the three main oxides of iron, the other two being iron(II) oxide (FeO), which is rare; and iron(II,III) oxide ( ... iron(III) oxide, the product's active ingredient, acting as antipruritic. The red color of iron(III) oxide is also mainly ... oxide is as the feedstock of the steel and iron industries, e.g. the production of iron, steel, and many alloys. A very fine ...
2,6-Pyridinedicarbothioic acid
It functions as a siderophore, a small chelating agent with a high affinity for iron. Siderophores are deployed as ion ... It is iron selective as only the Fe complex is soluble in water. PDTC is produced mainly during the exponential phase of ... An iron(II) complex of pyridine-2,6-di-(monothiocarboxylic acid) - a novel bacterial metabolic product", Tetrahedron Lett. 1978 ... "Metal chelating properties of pyridine-2,6-bis(thiocarboxylic acid) produced by Pseudomonas spp. And the biological activities ...
Iron overload
... there are chelating agents available for use. The drug deferoxamine binds with iron in the bloodstream and enhances its ... The human diet contains iron in two forms: heme iron and non-heme iron. Heme iron is the most easily absorbed form of iron. ... People with iron overload may be advised to avoid food that are high in heme iron. Highest in heme iron is red meat such as ... Human iron metabolism Iron deficiency Hsu CC, Senussi NH, Fertrin KY, Kowdley KV (June 2022). "Iron overload disorders". ...
Salicylic acid
... as its conjugate base is a chelating agent, with an affinity for iron(III). Salicylic acid slowly degrades to ... Chelating agents, Monohydroxybenzoic acids, Nonsteroidal anti-inflammatory drugs, Plant hormones, World Health Organization ... Aminosalicylic acid is used to induce remission in ulcerative colitis, and has been used as an antitubercular agent often ...
Hydroponics
Chelating agents and humic acid have been shown to increase nutrient uptake. Additionally, plant growth promoting rhizobacteria ... Depending on the pH or on the presence of water contaminants, nutrients such as iron can precipitate from the solution and ... Routine adjustments to pH, buffering the solution, or the use of chelating agents is often necessary. Unlike soil types, which ... sulfate or iron. Using chemical equipment for hydroponic solutions can be beneficial to growers of any background because ...
Ferric EDTA
EDTA (and other chelating agents) address this problem, by forming soluble complexes that resist formation of hydroxides. ... In horticulture, iron chelate is often referred to as 'sequestered iron' and is used as a plant tonic, often mixed with other ... In iron chelation therapy, deferoxamine, has been used to treat excess iron stores, i.e. haemochromatosis. DTPA EDDHA Tartrate ... Aside from ferric EDTA, iron complex of EDDHA is used to make the iron soluble in water and, for the purposes of agriculture, ...
Chelates in animal nutrition
"Chelating agents" are ligands that bind metal ions through more than one bond. Most chelating agents are organic compounds, e.g ... Some metals are more abundant in nature, such as zinc (as Zn2+), iron (as Fe2+ and Fe3+), and magnesium (as Mg2+). Some trace ... A variety of chelating agents are used, such as peptides and amino acids derived from hydrolysed soy proteins, which form amino ... is jargon for metal complexes of chelating agents. *Chelates are organic molecules, normally consisting of 2 organic parts with ...
Transition metal carboxylate complex
Related to these synthetic chelating agents are the amino acids, which form large families of amino acid complexes. Two amino ... which function as ligands for iron in nonheme iron proteins, such as hemerythrin. Brignole, Alicia B.; Cotton, F. A. (1972). " ... Strong alkylating agents are required. Metal organic frameworks, porous, three-dimensional coordination polymers, are often ... an O2-carrying iron-carboxylate A commercially important family of metal carboxylates are derived from aminopolycarboxylates, e ...
Transition metal alkene complex
Butadiene, cyclooctadiene, and norbornadiene are well-studied chelating agents. Trienes and even some tetraenes can bind to ... Benzylideneacetone)iron tricarbonyl, source of "Fe(CO)3". [[Et3P]2Pt]6(η2:η2:η2:η2:η2:η2-C60), a fullerene complex. Mo(C7H8)(CO ... Keto-alkenes are tetrahapto ligands that stabilize highly unsaturated low valent metals as found in (benzylideneacetone)iron ...
Rheumatoid arthritis
Deferioxamine, an iron-chelating agent, which has possible anti-inflammatory properties, causes haemoglobin and serum iron ... Biological agents should generally be used only if methotrexate and other conventional agents are not effective after a trial ... Approximately, one-third of cases of anaemia in RA patients may be caused by depletion of iron stores. A major cause for iron ... The most commonly used agent is methotrexate with other frequently used agents including sulfasalazine and leflunomide. ...
Myelodysplastic syndrome
... with iron chelating agents to address the question of whether iron chelation alters the natural history of patients with MDS ... These options now provide potentially useful drugs for treating the iron overload problem. A third chelating agent is available ... Reversal of some of the consequences of iron overload in MDS by iron chelation therapy has been shown. Both the MDS Foundation ... 10 or more iron granules encircling one-third or more of the nucleus) seen on Perls' Prussian blue iron stain (>15% ringed ...
Jan Aaseth
Protective measures include the therapeutic use of new iron chelating agents, which have been studied by Aaseth and co-workers ... Analyst, 123(1), 3-6. Aaseth J (1983). Recent advance in the therapy of metal poisonings with chelating agents. Human ... Pathological deposits of iron which occurs, e.g., in thalassemia can be treated by oral iron chelators, deferiprone (Ferriprox ... Iron deposition in the heart which is seen in transfusional sideroses, e.g., during treatment of thalassemia can precipitate ...
Rust
The iron is the reducing agent (gives up electrons) while the oxygen is the oxidizing agent (gains electrons). The rate of ... or removed with chelating agents as in some commercial formulations or even a solution of molasses. Rust is associated with the ... Rust is a general name for a complex of oxides and hydroxides of iron, which occur when iron or some alloys that contain iron ... Many other oxidation reactions exist which do not involve iron or produce rust. But only iron or alloys that contain iron can ...
Photographic processing
Water containing these chelating agents can leach metal from water treatment equipment as well as pipes. This is becoming an ... EDTA and other polyamine polycarboxylic acids are used as iron ligands in colour bleach solutions. These are relatively ... EDTA, DTPA, and NTA are very often used as chelating agents in all processing solutions, particularly in developers and washing ... However, due to poor biodegradability, these chelating agents are found in alarmingly high concentrations in some water sources ...
Phosphonate
... chelating agent EDTMP: Ethylenediaminetetra(methylenephosphonic acid), chelating agent TDTMP: Tetramethylenediaminetetra( ... Phosphonates in cooling water systems also serve to control corrosion of iron and steel. In pulp and paper manufacturing and in ... methylenephosphonic acid), chelating agent HDTMP: Hexamethylenediaminetetra(methylenephosphonic acid), chelating agent DTPMP: ... Phosphonates are effective chelating agents. That is, they bind tightly to di- and trivalent metal ions, which is useful in ...
Rebecca Abergel
... and characterised siderophore analogs to investigate how bacteria transport iron and to develop new iron chelating agents. ... In recent work by the BioActinide Research group, different actinide chelating agents have been synthesised which could be used ... "In Vitro Metabolism and Stability of the Actinide Chelating Agent 3,4,3-LI(1,2-HOPO)". Journal of Pharmaceutical Sciences. 104 ... Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents". Chemico-Biological ...
Iron poisoning
Deferoxamine is a drug that is used in cases of serious iron poisoning. It is a chelating agent and binds to free iron in the ... Any excess iron is stored as ferritin in the liver. In the event of iron overdose, iron stores become oversaturated and the ... When being transported throughout the body, iron is bound to an iron transporting protein called transferrin to prevent iron ... elemental iron per mg of mineral salt Ferrous fumarate contains 33% elemental iron per mg of mineral salt Iron toxicity is ...
Picolinic acid
495ff Picolinic acid is a bidentate chelating agent of elements such as chromium, zinc, manganese, copper, iron, and molybdenum ...
Avobenzone
As an enolate, avobenzone forms with heavy metal ions (such as Fe3+) colored complexes, and chelating agents can be added to ... The makers of Coppertone advise that avobenzone binds iron and can cause staining of clothes washed in iron-rich water. The ... Its ability to absorb ultraviolet light over a wider range of wavelengths than many other sunscreen agents has led to its use ... Manufacturers also recommend to avoid the inclusion of iron and ferric salts, heavy metals, formaldehyde donors and PABA and ...
List of food additives
Chelating Agent Egg - Egg yolk - Egg white - Elderberry - Eleutherococcus senticosus - Enzymatically hydrolyzed Carboxymethyl ... Iron ammonium citrate - Iron - Iron oxides and hydroxides - color Isobutane - propellant Isomalt - humectant Isopropyl citrates ... Flour treatment agents Flour treatment agents are added to flour to improve its color or its use in baking. Glazing agents ... Anticaking agents Anticaking agents keep powders such as milk powder from caking or sticking. Antifoaming agents Antifoaming ...
Porphyrin
Chelating agents, Porphyrins). ... A porphyrin with an iron atom of the type found in myoglobin, ... Porphyrins have been investigated as possible anti-inflammatory agents and evaluated on their anti-cancer and anti-oxidant ... A porphyrin-related disease: porphyria Porphyrin coordinated to iron: heme A heme-containing group of enzymes: Cytochrome P450 ... the main end-product protoporphyrin IX is combined with iron to form heme. Bile pigments are the breakdown products of heme. ...
Binding selectivity
In the case of iron overload, which may occur in individuals with β-thalessemia who have received blood transfusions, the ... The further use of quantitative structure-activity relationships (QSAR) led to the development of other agents such as ... Chelation therapy is a form of medical treatment in which a chelating ligand is used to selectively remove a metal from the ... ISBN 978-0-87983-730-3. Iron-Selective Chelators With Therapeutic Potential in Hider, Robert C.; Kong, Xiaole (2013). "Chapter ...
Aceruloplasminemia
Treatment includes the use of iron chelating agents (such as desferrioxamine) to lower brain and liver iron stores, and to ... Iron accumulation in the tissues and organs results in a corresponding iron deficiency in the blood, leading to anemia. Anemia ... Human iron metabolism Iron overload disorder "Aceruloplasminemia , Genetic and Rare Diseases Information Center (GARD) - an ... When ceruloplasmin is unavailable, transport of iron out of the body's tissues is impaired. The resulting iron accumulation ...
Catechol
Chelating agents, Enediols, IARC Group 2B carcinogens, Photographic chemicals, Reducing agents). ... Iron-containing dioxygenase enzymes catalyze the cleavage of catechol. Catechols convert to the semiquinone radical. At pH = 7 ... urushiols, the active agent in poison ivy (R = (CH2)14CH3, (CH2)7CH=CHCH2CH=CHCH2CH=CH2, and others) catecholamines, drugs ... CO Basic solutions of catechol react with iron(III) to give the red [Fe(C6H4O2)3]3−. Ferric chloride gives a green coloration ...
1,10-Phenanthroline
Chelating agents, Phenanthrolines). ... iron(II) and -iron(III) Complexes". Inorganic Chemistry. 49 (9 ... and an oxidizing agent, traditionally aqueous arsenic acid or nitrobenzene. Dehydration of glycerol gives acrolein which ...
BDTH2
The compound was reported in about 1994 after a search for chelating agents selective for mercury. It was licensed in 2006 to ... Poster: Complete Remediation of Groundwater Arsenic Using a Merloc B9, Zerovalent Iron Filtration Column (PDF-file; 8,38 MB) ( ... iron, and mercury from ground water, coal tailings, gold ore, waste water of battery-recycling plants, and contaminated soil. ... is an organosulfur compound that is used as a chelation agent. It is a colourless solid. The molecule consists of two thiol ...
Diene
Hayashi T, Ueyama K, Tokunaga N, Yoshida K (2003). "A Chiral Chelating Diene as a New Type of Chiral Ligand for Transition ... For example, 1,5-hexadiene and 1,9-decadiene, useful crosslinking agents and synthetic intermediates, are produced from 1,5- ... Other diene complexes include (butadiene)iron tricarbonyl, cyclobutadieneiron tricarbonyl, and cyclooctadiene rhodium chloride ... Dienes are widely used chelating ligands in organometallic chemistry. In some cases they serve as placeholder ligands, being ...
Fouling
Examples for water systems are: chelating agents (for example, EDTA), long-chain aliphatic amines or polyamines (for example, ... iron oxides and iron oxyhydroxides (magnetite, hematite, lepidocrocite, maghemite, goethite); Sedimentation fouling by silt and ... An example of corrosion fouling can be formation of an iron oxide or oxyhydroxide deposit from corrosion of the carbon steel ... low-iron water. The deposition rate by precipitation is often described by the following equations: Transport: d m d t = k t ( ...
Soybean
... s contain phytic acid, which may act as a chelating agent and inhibit mineral absorption, especially for diets already ... It has higher levels of protein, thiamine, riboflavin, phosphorus, calcium, and iron than wheat flour. It does not contain ... iron (121%), manganese (120%), phosphorus (101%) and several B vitamins, including folate (94%) (table). High contents also ...
Ferrichrome
... are metal chelating agents that have a low molecular mass and are produced by microorganisms and plants growing under low iron ... Although iron is the fourth most abundant element in the earth's crust, bioavailability of iron in aerobic environments is low ... Under iron limitation, bacteria scavenge for ferric iron (Fe3+) by up-regulating the secretion of siderophores in order to meet ... The reduction strategy helps in making the iron more aqueous soluble, and allows the iron to become more bioavailable in order ...
Sodium dithionite
... allows it to enhance the solubility of iron, and therefore dithionite is a useful chelating agent. Aqueous solutions of sodium ... Hence, iron extracted by sodium dithionite is also referred to as "free iron." The strong affinity of the dithionite ion for bi ... often as a decolourising agent. It is even used domestically as a decoloring agent for white laundry, when it has been ... It is the an active ingredient in "Iron Out Rust Stain Remover", a commercial rust product. Sodium dithionite is often used in ...
Hans Reese
Peters HA, Woods S, Eichman PL, Reese HH: The treatment of acute porphyria with chelating agents: a report of 21 cases. Ann ... He was a combatant in the Battle of Jutland, and was awarded the Iron Cross and the Hanseatic Cross. After returning to ... Recipients of the Iron Cross (1914), Recipients of the Hanseatic Cross, People from the Province of Schleswig-Holstein, ...
Poison
... unless specific chelating agents or micro-filtration processes are available. Chelating agents are often broader in scope than ... iron), and for removal of ingested drug packets (body packing/smuggling). In some situations elimination of the poison can be ... Agents that act on the nervous system can paralyze in seconds or less, and include both biologically derived neurotoxins and so ... In industry the term may be negative, something to be removed to make a thing safe, or positive, an agent to limit unwanted ...
List of MeSH codes (D27)
... chelating agents MeSH D27.505.519.249.410 - iron chelating agents MeSH D27.505.519.249.410.750 - siderophores MeSH D27.505. ... iron chelating agents MeSH D27.720.233.173 - chromogenic compounds MeSH D27.720.233.348 - fluorescent dyes MeSH D27.720.233.674 ... antiviral agents MeSH D27.505.954.122.388.077 - anti-retroviral agents MeSH D27.505.954.122.388.077.088 - anti-hiv agents MeSH ... tocolytic agents MeSH D27.505.954.016 - anti-allergic agents MeSH D27.505.954.122 - anti-infective agents MeSH D27.505.954.122. ...
Aspergillomarasmine A
... functions as a chelating agent, sequestering Fe3+ ions. It can inhibit endothelin converting enzymes even ... Barbier, M. (1987). "Remarks on the biological activity of aspergillomarasmine A Fe3+ chelate and other iron transporting ... in the live rat, probably by chelating metals required by metalloproteases. When heated, aspergillomarasmine A decomposes ...
Iron
The medical management of iron toxicity is complicated, and can include use of a specific chelating agent called deferoxamine ... the world's accessible iron ore is located Iron and steel industry Iron cycle Iron nanoparticle Iron-platinum nanoparticle Iron ... Iron(II) chloride is used as a reducing flocculating agent, in the formation of iron complexes and magnetic iron oxides, and as ... Iron forms compounds mainly in the oxidation states +2 (iron(II), "ferrous") and +3 (iron(III), "ferric"). Iron also occurs in ...
Transition metal porphyrin complexes
Biomolecules, Chelating agents, Porphyrins). ... Iron porphyrin complexes occur widely in Nature, which has ... Iron porphyrin complexes ("hemes") are the dominant metalloporphyrin complexes in nature. Consequently, synthetic iron ... ISBN 978-0-7167-4878-6. Chang, C. K.; DiNello, R. K.; Dolphin, D. (1980). "Iron Porphines". Inorg. Synth. 20: 147. doi:10.1002/ ...
Aluminium triacetate
A mordant often contains a polyvalent metal ion, commonly aluminium or iron, as is the case with mixtures of aluminium ... Aluminium triacetate is used as a mordant agent with dyes like alizarin, both alone and in combination. Together with aluminium ... with two alizarin moieties each chelating to each aluminium centre. The structure was proposed by Soubayrol et al. based on ... Other trivalent metal cations are known to form polynuclear species: iron(III) acetate, for example, forms a trinuclear ...
Deferoxamine
... which can greatly increase the amount of iron in the body. Treatment with iron-chelating drugs such as deferoxamine reduces ... This agent is also frequently used to treat hemochromatosis, a disease of iron accumulation that can be either genetic or ... By removing excess iron from persons with hemochromatosis, the agent reduces the damage done to various organs and tissues, ... Deferoxamine is produced by removal of the trivalent iron moiety from ferrioxamine B, an iron-bearing sideramine produced by ...
Uranium
UO2+ 2 also forms complexes with various organic chelating agents, the most commonly encountered of which is uranyl acetate. ... Along with all elements having atomic weights higher than that of iron, uranium is only naturally formed by the r-process ( ... and was used as a coloring agent in the local glassmaking industry. In the early 19th century, the world's only known sources ...
Rhodotorulic acid
5-diketopiperazine family of hydroxamate siderophores which are high-affinity chelating agents for ferric iron, produced by ... It is a tetradentate ligand, meaning it binds one iron atom in four locations (two hydroxamate and two lactam moieties), and ... Van der Helm D, Winkelmann G (February 1994). "Hydroxamates and Polycarboxylates as Ion Transport Agents (Siderophores)". In ... forms Fe2(siderophore)3 complexes to fulfill an octahedral coordination for iron. Rhodotorulic acid occurs in basidiomycetous ...
1,2-Bis(diphenylphosphino)benzene
Chelating agents, Diphosphines, Phenyl compounds). ... "Iron-catalysed fluoroaromatic coupling reactions under ... As a chelating ligand, dppbz is very similar to 1,2-bis(diphenylphosphino)ethylene. Hatakeyama, Takuji; Kondo, Yoshiyuki; ...
Anthracycline
... used to treat anthracyclines post-extravasation by acting as a topoisomerase II inhibitor as well as a chelating agent to ... In addition, the availability of cellular iron catalyses redox reactions and further generates ROS. The excessive ROS that ... Anti-Cancer Agents. 1 (2): 113-30. doi:10.2174/1568011013354723. PMID 12678762. Angsutararux P, Luanpitpong S, Issaragrisil S ( ... Anthracyclines remain some of the most widely used chemotherapeutic agents but their potential is limited by its dose-limiting ...
Deferasirox
Chelating agents, Chelating agents used as drugs, Orphan drugs, Novartis brands, Antidotes, Triazoles, Benzoic acids, Phenols) ... is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood ... deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from ... It is approved in the European Union by the European Medicines Agency (EMA) for children six years and older for chronic iron ...
Article Metrics] Effects of Iron Chelating Agents in Thalassemia Major | OPTH
Transfusion-Induced Iron Overload Medication: Chelating Agents
Iron homeostasis thus relies on the amount that is absorbed from the small intestine. ... The human body has no active mechanism for the excretion of iron. ... Chelating Agents. Class Summary. Chelating agents help reduce iron levels in the body by promoting the excretion of chelated ... and rid the body of all excess iron, thereby preserving organ function. [13] Three iron-chelating agents are available: ...
Steam iron cleaner poisoning: MedlinePlus Medical Encyclopedia
Poisoning occurs when someone swallows steam iron cleaner. ... Steam iron cleaner is a substance used to clean steam irons. ... The harmful chemicals in steam iron cleaner are:. *Chelating agents. *Hydroxyacetic acid ... Steam iron cleaner is a substance used to clean steam irons. Poisoning occurs when someone swallows steam iron cleaner. ... How well someone does depends on how much steam iron cleaner they swallowed and how quickly they receive treatment. The faster ...
Aplastic Anemia: Practice Essentials, Background, Etiology
Antimetabolite (purine) antineoplastic agents (eg, fludarabine). * Iron-chelating agents (eg, deferoxamine, deferasirox) ... Improving Quality of Care in Patients With Iron Deficiency Anemia and Inflammatory Bowel Disease 0.5 CME / CE / ABIM MOC ... Immunosuppressive agents (eg, cyclosporine, methylprednisolone, equine antithymocyte globulin, rabbit antithymocyte globulin, ... Improving Quality of Care in Patients With Iron Deficiency Anemia and Inflammatory Bowel Disease ...
IMSEAR at SEARO: Efficacy and safety of oral iron chelating agent deferiprone in beta-thalassemia and hemoglobin E-beta...
CONCLUSIONS: DFP is an effective and fairly well tolerated oral iron chelating agent. The side effects that occur can be ... OBJECTIVES: To assess efficacy and safety of oral iron chelating agent deferiprone (DFP) in patients with beta thalassemia and ... Efficacy and safety of oral iron chelating agent deferiprone in beta-thalassemia and hemoglobin E-beta thalassemia. ... Efficacy and safety of oral iron chelating agent deferiprone in beta-thalassemia and hemoglobin E-beta thalassemia. Indian ...
Transfusion-Induced Iron Overload Workup: Laboratory Studies, Imaging Studies, Other Tests
Iron homeostasis thus relies on the amount that is absorbed from the small intestine. ... The human body has no active mechanism for the excretion of iron. ... Pharmacogenetic study of deferasirox, an iron chelating agent. PLoS One. 2013. 8(5):e64114. [QxMD MEDLINE Link]. [Full Text]. ... Iron-chelating therapy for transfusional iron overload. N Engl J Med. 2011 Jan 13. 364(2):146-56. [QxMD MEDLINE Link]. [Full ...
NIOSHTIC-2 Search Results - Full View
Combined chelation therapy with deferasirox and deferoxamine in thalassemia
Iron overload is the primary cause of mortality and morbidity in thalassemia major despite advances in chelation therapy. We ... Iron Chelating Agents / administration & dosage * Iron Chelating Agents / therapeutic use* * Iron Overload / drug therapy* ... Iron overload is the primary cause of mortality and morbidity in thalassemia major despite advances in chelation therapy. We ... In the 18 subjects completing 12 months of therapy, median liver iron concentration decreased by 31% from 17.4 mg/g (range 3.9- ...
Deferasirox Accord | European Medicines Agency
Iron chelating agents. Therapeutic indication. Deferasirox Accord is indicated for the treatment of chronic iron overload due ... Deferasirox Accord is a medicine used to treat chronic iron overload (an excess of iron in the body) in:. *patients from 6 ... The active substance in Deferasirox Accord, deferasirox, is an iron chelator. It attaches to excess iron in the body to form ... This helps to correct the iron overload and prevents damage to organs such as the heart or liver from excess iron. ...
Role of Flavonoids in the Treatment of Iron Overload. | GreenMedInfo
Role of flavonoids in the treatment of iron overload. ... Iron chelating agents are often used for treatment but, at ... In addition, the advantages and disadvantages of flavonoids as plant iron chelating agents are discussed to provide a ... and inhibit the lipid peroxidation process caused by iron overload. Therefore, flavonoids with iron chelating and antioxidant ... Recent studies have shown that flavonoids can affect iron status, reduce iron deposition, ...
Pharmaceutical products list 44
Chelating Agents *Chelatran - SERB Laboratoires *Chelazome Calcium - Trophic Canada *Chelazome Copper - Trophic Canada * ... Chelated Iron - Albion Laboratories *Chelated Iron - Gahler Enterprises *Chelated Iron - Health-Wise Nutrition *Chelated ... Chela Iron Plus C, B Complex - Nu-Life Nutrition *Chela Potassium Plus - Nu-Life Nutrition *Chela Zinc Plus - Nu-Life Nutrition ... Chelazome Iron - Trophic Canada *Chelazome Magnesium - Trophic Canada *Chelazome Manganese - Trophic Canada *Chelazome Zinc - ...
Registration Dossier - ECHA
Design of novel mitochondria-targeted fluorescent iron sensor for the monitoring of mitochondrial labile iron pool level -...
Iron Chelator 100% * Mitochondria 41% * Iron 40% * Chelating Agents 35% * Peptide 32% ... Mitochondrial and Lysosomal-Targeted Iron Chelators for the Monitoring and Adjustment of Cellular Labile Iron Pools. Pourzand, ... Design of novel mitochondria-targeted fluorescent iron sensor for the monitoring of mitochondrial labile iron pool level. ...
Dilated Cardiomyopathy: Practice Essentials, Background, Pathophysiology
Dexrazoxane is an iron-chelating agent approved by the FDA to reduce toxicity; however, it increases the risk of severe ... 63] Iron accumulates first in the ventricular myocardium and then the atrial myocardium. [64] As iron itself is proarrhythmic, ... Hemochromatosis (iron overload cardiomyopathy). Iron deposition in the myocardium initially manifests as diastolic dysfunction ... Iron overload is characterized by a transferrin saturation above 55% and a transferrin level over 200 ng/mL for women and over ...
Number of ongoing Clinical Trials (for drugs) involving Hemochromatosis by Phase - GlobalData
Deferasirox is an iron chelating agent. It functions via Iron Chelator mechanism of action. It is formulated as tablets for ... Deferoxamine mesylate (Desferal) is an iron-chelating agent. It functions via Iron Chelator mechanism of action. It is ... Deferasirox is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in ... and Iron Poisoning. Deferoxamine mesylate was first approved in 1963 and is marketed globally including the US, the UK, ...
WHOCC - ATCvet Index
Hepatitis B - Life Extension
Silybin, a new iron-chelating agent. J. Inorg. Biochem. 2001;85(2-3):123-9 ... Mladěnka, P., Macáková, K., Filipský, T., et al.In vitro analysis of iron chelating activity of flavonoids. J. Inorg. Biochem. ... Iron-sequestering compounds. High serum and hepatic iron have been associated with a reduced response to IFN treatment and ... may also have iron-sequestering activity in addition to their anti-viral activity. More information is available in the Iron ...
Identifying Optimum Conditions for Stable Wormholes Created by Chelating Agents - KFUPM ePrints
5% DTPA and HEDTA chelating agents were found to be good iron control agents for 20% HCl acid. Core flooding studies showed ... None of the studied chelating was found to be suitable as iron control agent to be added to 20% HCl acid when sea water was ... They showed that chelating agents can effectively be used as stimulation fluids especially in the cases of high temperature and ... Solubility screening studies showed that DTPA and HEDTA chelating agents were soluble at pH values as low as 2.0 in all chelant ...
Profile | Biosciences | University of Exeter
Objectives the aim of this study was to assess the safety and efficacy of adding a novel iron-chelating agent, CP94 (1,2- ... Objectives the aim of this study was to assess the safety and efficacy of adding a novel iron-chelating agent, CP94 (1,2- ... Objectives the aim of this study was to assess the safety and efficacy of adding a novel iron-chelating agent, CP94 (1,2- ... Campbell SM, Morton CA, Alyahya R, Horton S, Pye A, Curnow A (2008). Clinical investigation of the novel iron-chelating agent, ...
https://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq
... disease-modifying agents, and allogeneic stem cell transplantation. Get detailed information about the treatment of newly ... The availability of the oral iron-chelating agent deferasirox has led to its widespread use in patients with MDS. While some ... Classic chemotherapy agents associated with these disorders include alkylating agents, topoisomerase inhibitors, and purine ... Wijermans P, Lübbert M, Verhoef G, et al.: Low-dose 5-aza-2-deoxycytidine, a DNA hypomethylating agent, for the treatment of ...
Ventrixyl Fe: Package Insert / Prescribing Information - Drugs.com
For specific therapy, exchange transfusion and chelating agents should be used. For general management, perform gastric lavage ... Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, ... Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product ... Although the absorption of iron is best when taken between meals, giving Ventrixyl â„¢ FE after meals may control occasional ...
Congenital Dyserythropoietic Anemia | Boston Children's Hospital
medications, such as iron chelating agents or interferon alpha-2A (only in CDA type I) ... After age 20 some children develop iron overload. *Type 3: The liver is not affected, but eye and blood problems are present. ... Type 1: Moderate to severe anemia including jaundice; hepatosplenomegaly (enlargement of the liver and spleen) as well as iron ... Our program provides comprehensive care for children with all types of rare anemias and iron disorders, as well as ongoing ...
permalink
The chelating agent binds to the metal (and/or metals), making it water soluble -- and hence unable to bind to something else ... a mercury atom for a calcium or an iron, but it has a few billions sisters following it. One of them is bound to pick it up and ... And I dont think you can find chelating agents which will be good for catching both the metal form and any of the oxide form. ... In the context of repeatedly injecting big amounts of chelating agents, in addition to the body own processes of heavy metal ...
Free Nursing Flashcards about pediatric hema diso
An iron chelating agent is given with oral supplements of vitamin C. A splenectomy may be necessary. ... Reduced fetal Iron supply give iron supplement with juice. what factors may cause iron deficiency?. Decrease supply of Iron ( ... therapy for iron deficiency. Diet counseling and iron supplements. Ferrous Sulfate Supplement with iron-fortified infant ... Give an iron-fortified formula. Overweight does not mean healthy. Name three causes of iron-deficiency anemia.. Severe ...
Involvement of Free Radicals in the Development and Progression of Alzheimer's Disease | IntechOpen
90] showed that the prolonged administration of an iron-chelating agent, desferrioxamine, slowed the development of the disease ... Iron:. Divalent iron (Fe2+) is the most abundant transition metal in the human brain. Iron is present in vivo. in both the ... studies have shown that •OH can be generated when Fe3+ is reduced in the presence of reducing agents such as ascorbic acid (5) ... The O2•− can reduce and liberate ferric ion (Fe3+) from ferritin or ferrous ion (Fe2+) from iron-sulfur clusters. This reaction ...
Antioxidants | Free Full-Text | Cordyceps militaris Reduces Oxidative Stress and Regulates Immune T Cells to Inhibit Metastatic...
Reducing power, chelating ability, and 2,2-diphenyl-2-picrylhydrazyl (DPPH) assays were applied for antioxidative capacities, ... removal of iron ions is one of the things that can be achieved. In the medium of chelating agent, the structure cause complex ... The ferrous ion chelating assay could examine the compounds as chelating agents to disrupt the ROS construction by lightening ... Ferrous Ion Chelating Assay. The antioxidant properties of iron were analyzed by the results of iron chelation; however, ...
DeferoxamineDeferasiroxOverloadEDTAIonsDeferiproneChelatorsChelatesTransferrinSubstancesNoninvasiveToxicityFlavonoidsHemochromatosisDepositionFree radicalsTransfusionChelateCalciumSubcutaneousSodiumClinicalBindsSerumManganeseThalassaemiaOxidesTherapyAnemiaHemoglobinMedicationChelationMetalsEfficacyMyocardialInfusionSubstanceSystemic ironTreatmentMetalOrganicCopperWidelyPatient'sAbsorption of ironSevereOral iron chelaExcessAccidentalGastricExcretionMechanismDysfunctionToxicPatientsSymptoms2021HepaticHigh
Deferoxamine8
- Approximately 8 mg of iron is bound by 100 mg of deferoxamine, forming a 1:1 hexadentate complex. (medscape.com)
- We performed a pilot clinical trial to evaluate the safety and efficacy of combined therapy with deferasirox (DFX, 20-30 mg/kg daily) and deferoxamine (DFO, 35-50mg/kg on 3-7 days/week) in 22 patients with persistent iron overload or organ damage. (nih.gov)
- After thorough explanation of the treat- and short half-life which can form a trans- ment and the study, written consent was portable deferoxamine-iron complex or obtained from patients or their parents. (who.int)
- Deferoxamine mesylate (Desferal) is an iron-chelating agent. (globaldata.com)
- Deferoxamine mesylate is marketed for the treatment of Hemochromatosis and several other indications including Thalassemia , Acquired (Autoimmune) Hemolytic Anemia, and Iron Poisoning. (globaldata.com)
- This study examined the effect of deferoxamine, an iron-chelating agent, in the treatment of paraquat poisoning. (koreamed.org)
- The effectiveness of deferoxamine as a therapeutic approach to iron overload has been proved in the previous studies. (ijo.in)
- [6] , [8] Deferiprone and deferasirox are two new iron chelation drugs that have been introduced for clinical use as an orally effective substitute for deferoxamine. (ijo.in)
Deferasirox8
- The dose for deferasirox is 20 mg/kg/day orally once daily, and then increased by 5 to 10 mg every three to six months based on levels of iron stores. (medscape.com)
- The starting dose of Deferasirox Accord depends on the patient's body weight, what the medicine is used for, and the level of iron overload. (europa.eu)
- Deferasirox is an iron chelating agent. (globaldata.com)
- Deferasirox is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older. (globaldata.com)
- Deferasirox is a chelator used clinically for iron overload, but also is cytotoxic to cells in culture. (duke.edu)
- In order to test whether a prodrug version of deferasirox could minimize its cytotoxicity but retain its protective properties against iron-induced oxidative damage, we synthesized a prochelator that contains a self-immolative boronic ester masking group that is removed upon exposure to hydrogen peroxide to release the bis-hydroxyphenyltriazole ligand deferasirox. (duke.edu)
- These results imply that the cytotoxicity of deferasirox may not derive exclusively from its iron withholding properties. (duke.edu)
- Pharmacogenetic study of deferasirox, an iron chelating agent. (cdc.gov)
Overload32
- The goals of pharmacotherapy in cases of transfusion-induced iron overload are to protect tissues from damage caused by iron, decrease plasma and cytosolic levels of reactive labile iron to normal, and rid the body of all excess iron, thereby preserving organ function. (medscape.com)
- Approved to treat chronic iron overload due to multiple blood transfusions. (medscape.com)
- It is indicated for adults and children aged 3 years and older with iron overload from transfusion for thalassemia syndromes, sickle cell disease, or other anemias. (medscape.com)
- Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes. (medscape.com)
- To date, no perfect laboratory marker for iron overload exists. (medscape.com)
- Serum ferritin has been extensively used as an easily accessible serum marker for transfusion-induced iron overload. (medscape.com)
- Serum iron is increased in cases of iron overload and the total iron-binding capacity (TIBC) is decreased. (medscape.com)
- NTBI and LPI are very specific for iron overload and have promising value as monitoring parameters for clinical response to chelation therapy. (medscape.com)
- [ 50 ] However, the lack of a standardized assay and limited data for general use for transfusion-induced iron overload makes it necessary to further investigate the use of NTBI and LPI. (medscape.com)
- Computed tomography (CT) scanning has a limited sensitivity (63%) for the assessment of hepatic iron overload. (medscape.com)
- however, a normal hepatic CT density does not exclude iron overload. (medscape.com)
- Superconducting quantum interference device (SQUID) magnetic measurements of liver iron in patients with iron overload are quantitatively equivalent to biochemical determinations on tissue obtained by biopsy. (medscape.com)
- MRI is useful to assess pituitary iron overload in patients with transfusional hemochromatosis and secondary hypogonadism by detection of a significant decreased signal intensity of the anterior lobe of the pituitary gland on T2-weighted images. (medscape.com)
- Iron overload is the primary cause of mortality and morbidity in thalassemia major despite advances in chelation therapy. (nih.gov)
- In these patients, iron overload is caused by excess absorption of iron from the gut. (europa.eu)
- The medicine can only be obtained with a prescription and treatment should be started and supervised by a doctor who is experienced in the treatment of chronic iron overload. (europa.eu)
- This helps to correct the iron overload and prevents damage to organs such as the heart or liver from excess iron. (europa.eu)
- Role of Flavonoids in the Treatment of Iron Overload. (greenmedinfo.com)
- Iron overload, a high risk factor for many diseases, is seen in almost all human chronic and common diseases. (greenmedinfo.com)
- Recent studies have shown that flavonoids can affect iron status, reduce iron deposition, and inhibit the lipid peroxidation process caused by iron overload. (greenmedinfo.com)
- In this study, we not only reviewed the research progress of iron overload and the regulation mechanism of flavonoids, but also studied the structural basis and potential mechanism of their function. (greenmedinfo.com)
- hepatosplenomegaly (enlargement of the liver and spleen) as well as iron overload. (childrenshospital.org)
- After age 20 some children develop iron overload. (childrenshospital.org)
- [3] , [4] Iron-chelation therapies are frequently used to minimize iron overload in these patients. (ijo.in)
- however, this potential is countered by risks of indiscriminant metal binding or iron depletion in conditions not associated with systemic iron overload. (duke.edu)
- Despite better survival due to blood transfusion and iron chelation therapy, the previously unrecognized renal complication remain a burden of disease affecting this population -the primary concern on how iron overload and chelation therapy correlated with renal impairment is still controversial. (bvsalud.org)
- Therefore, a systematic review was performed to identify markers of kidney complications in beta thalassemia patients with iron overload receiving chelation therapy. (bvsalud.org)
- Methods: Searches of PubMed, Scopus, Science Direct, and Web of Science were conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) to identify studies of literature reporting renal outcome in ß-TM patients with iron overload and receiving chelation therapy. (bvsalud.org)
- Discussion and Conclusion: The renal complication in beta-thalassemia patients with iron overload receiving chelating agent therapy may progress to kidney disease. (bvsalud.org)
- tissue hypoxygenation and iron overload. (who.int)
- Haemoglobinopathies, including thalassaemia, are con- sources of iron overload are repeated transfusions and sidered a serious health care burden worldwide. (who.int)
- 480 000 individuals, showed such as red cell alloimmunization ( 11 , 12 ), transmission of that 3.22% of the screened population were carriers, and chronic infections ( 11 - 13 ), iron overload leading to tissue around 0.07% had thalassaemia ( 7 ). (who.int)
EDTA2
- Calcium and Rion content in Paper after Washing With Chelating Agents (EDTA, DTPA) and Reducing Bleachig Agents (Sodium Dithioite and Sodium Borohydride). (uib.no)
- Sodium EDTA is a water-soluble acid that is a strong emulsion stabilizer with chelating properties. (jivanamnutrition.com)
Ions8
- Metal indicators and chelating agents are used to determine the concentration of specific metal ions in solution by chelate titration. (dojindo.com)
- Colorimetric chelating reagents form colored complexes with metal ions in pH-controlled solutions. (dojindo.com)
- Thus, iron can be determined without interference from other metal ions. (dojindo.com)
- Water-soluble colorimetric chelating agents enable the determination of metal ions in aqueous solution without solvent extraction. (dojindo.com)
- Maximum chelating of metals ions at 1000 μg mL -1 of extract and standard was found to be 63.9 and 89%, respectively. (scialert.net)
- The multivalent metal ions most commonly used are calcium, aluminium and iron. (theholidayprojectweb.es)
- HEDP is a chelating agent and may be added to bind or, to some extent, counter the effects of substances, such as calcium, iron or other metal ions, which may be discharged as a component of grey wastewater and could conceivably contaminate groundwater supplies. (oilfieldchemicals.in)
- An effective chelating agent, binding to metal ions making emulsions more stable and allowing washes and soaps to develop a thick, rich lather. (keratinandcare.com)
Deferiprone3
- IMSEAR at SEARO: Efficacy and safety of oral iron chelating agent deferiprone in beta-thalassemia and hemoglobin E-beta thalassemia. (who.int)
- Adhikari D, Roy TB, Biswas A, Chakraborty ML, Bhattacharya B, Maitra TK, Basu AK, Chandra S. Efficacy and safety of oral iron chelating agent deferiprone in beta-thalassemia and hemoglobin E-beta thalassemia. (who.int)
- OBJECTIVES: To assess efficacy and safety of oral iron chelating agent deferiprone (DFP) in patients with beta thalassemia and hemoglobin E-beta thalassemia. (who.int)
Chelators3
- 1,2 dimethyl-3-hydroxypyridine-4-one is a member of a family of hydroxypyridine-4-one (HPO) chelators that requires 3 molecules to fully bind iron (III), each molecule providing 2 coordination sites (bidentate chelation). (medscape.com)
- Effect of iron chelators on paraquat toxicity in rats and alveolar type II cells. (koreamed.org)
- Metal indicators, colorimetric metal chelators, and fluorometric metal chelators are chromogenic chelating agents. (dojindo.com)
Chelates1
- Readily chelates iron from ferritin and hemosiderin but not from transferrin. (medscape.com)
Transferrin2
- [ 49 ] A transferrin saturation above 50% is suggestive of a high iron load, but this is a dynamic number and may vary with inflammation. (medscape.com)
- The mean±S.E. plasma non-transferrin-bound iron (NTBI) declined from 3.10±0.25μM to 2.15±0.29μM (p=0.028). (nih.gov)
Substances1
- Also, humic substances and various other organic compounds function as natural chelating agents of iron & other transition metals. (ukaps.org)
Noninvasive1
- Sub-Saharan regions, with the high rates of immigration, and parenteral iron chelating agents, noninvasive and their prevalence has increased globally ( 1 - 4 ). (who.int)
Toxicity9
- Mechanisms of iron loading and toxicity. (medscape.com)
- The ferritin level that has been used as a cutoff point for iron toxicity has varied in studies from 1000 ng/mL to 3000 ng/mL. (medscape.com)
- The simultaneous administration of DFO and DFX rapidly reduced systemic and myocardial iron, and provided an excellent control of the toxic labile plasma iron species without an increase in toxicity. (nih.gov)
- [7] Thus, there was a great need for development of an alternative iron-chelator based on three main criteria namely oral activity, low cost, and low toxicity. (ijo.in)
- If this is the case, overdosing iron & other metals would hardly save them, but it can reach the levels where toxicity is the problem. (ukaps.org)
- Iron toxicity from an intentional or accidental ingestion is a common poisoning. (mhmedical.com)
- Vomiting is the clinical sign most consistently associated with acute iron toxicity. (mhmedical.com)
- The absence of these symptoms within 6 hours of ingestion essentially excludes a diagnosis of significant iron toxicity. (mhmedical.com)
- When determining a patient's potential for toxicity, the total amount of elemental iron must be used in calculations. (mhmedical.com)
Flavonoids4
- Therefore, flavonoids with iron chelating and antioxidant activities may become potential complementary therapies. (greenmedinfo.com)
- In addition, the advantages and disadvantages of flavonoids as plant iron chelating agents are discussed to provide a foundation for the prevention and treatment of iron homeostasis disorders using flavonoids. (greenmedinfo.com)
- The flavonoids of sacred lotus flowers by possessing scavenging free radicals action and iron chelating action exhibits potential antioxidant activity. (dermaessentia.com)
- The flavonoids of this flower also act as vein-active agents by reducing the permeability and improving the blood capillaries resistance. (dermaessentia.com)
Hemochromatosis1
- also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. (drugs.com)
Deposition3
- Helps prevent damage to the liver and bone marrow from iron deposition. (medscape.com)
- However, older thalassaemics may have to contend with multiple conditions including early osteoporosis, cardiac disease, pulmonary hypertension and diabetes, some of which result from increased iron deposition in the endocrine glands and myocardial cells. (who.int)
- [2] Although this treatment alleviates anemia, it leads to massive tissue deposition of iron and may eventually result in multi-organ dysfunction. (ijo.in)
Free radicals1
- The results indicate that the free radicals generated by wood smoke through the reaction of Fe with H(2)O(2) are able to cause DNA and cellular damage and may act as a fibrogenic agent. (cdc.gov)
Transfusion3
- Dosing an be changed by 5 to 10 mg every three to six months depending on transfusion burden and iron status of the patient. (medscape.com)
- When treatment combining transfusion and iron-chelating agent is started early and maintained, the patient's quality of life can be very good and the prognosis is optimistic. (who.int)
- For specific therapy, exchange transfusion and chelating agents should be used. (nih.gov)
Chelate7
- It attaches to excess iron in the body to form a compound called a 'chelate' that can be removed by the body, mainly in the stool. (europa.eu)
- The aim of this study was to assess ocular changes in thalassemia patients who have received multiple transfusions and chelate binding therapy in order to avoid iron accumulation. (ijo.in)
- The stability of the metal-chelate bond affects availability to plants of the micronutrient metals, namely copper, iron, manganese, and zinc. (prlog.org)
- In general, metal indicators are utilized for chelate titration, and colorimetric and fluorometric chelating agents are utilized for the determination of the metal concentration by spectrophotometry. (dojindo.com)
- The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (bvsalud.org)
- The metal-chelate solutions were analyzed before and after treatments used to remove the metal from the chelating agent. (theholidayprojectweb.es)
- The copper- and iron-chelate solutions were evaluated with all four treatments. (theholidayprojectweb.es)
Calcium1
- Serious Stain Remover combines potent organic acids with powerful chelating agents to dissolve mineral stains such as iron, calcium, manganese etc. (pioneerfamilypools.ca)
Subcutaneous1
- As a result of multiple transfusions over the years, various organs become severely overloaded with iron, and, in order to avoid death in adolescence, regular subcutaneous infusion of an iron-chelating agent is essential. (who.int)
Sodium1
- Sodium Acryloyldimethyl Taurate Copolymer is a gelling agent that helps to thicken, emulsifies, and balances products. (jivanamnutrition.com)
Clinical6
- [ 55 ] SQUID can also measure spleen iron content and can be used for monitoring the clinical response to chelation therapy. (medscape.com)
- Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. (exeter.ac.uk)
- Our program provides comprehensive care for children with all types of rare anemias and iron disorders, as well as ongoing medical management and access to new treatment approaches through our clinical research. (childrenshospital.org)
- Based on clinical findings, iron poisoning can be divided into 5 stages. (mhmedical.com)
- The diagnosis of iron poisoning is based on the clinical picture and the history provided by the patient, significant others, or EMS providers. (mhmedical.com)
- Table 110-1 reviews the predicted clinical effects based on the amount of iron ingested. (mhmedical.com)
Binds2
- Binds iron with high affinity in a 2:1 ratio (tridentate complex). (medscape.com)
- Children with very high lead levels in their blood (greater than or equal to 45 micrograms per deciliter (µg/dL) will likely be hospitalized to receive a medication called a chelating agent , which chemically binds with lead, allowing the body to excrete it naturally. (mo.gov)
Serum1
- The relationship between serum iron and total body iron is nonlinear, and the results are dependent on the method used. (medscape.com)
Manganese4
- For example, humans need iron, copper , cobalt, manganese, and zinc as long as the metals are not present in the blood in their free forms. (progressivehealth.com)
- The major micronutrients existing in the global market include boron (B), copper (Cu), iron (Fe), manganese (Mn), molybdenum (Mo) and zinc (Zn), and chloride (Cl), while chloride is a micronutrient whose deficiencies rarely occur in nature. (prlog.org)
- Iron and manganese control is the most common type of municipal water treatment in Minnesota. (theholidayprojectweb.es)
- Iron and manganese occur naturally in groundwater. (theholidayprojectweb.es)
Thalassaemia4
- Haemosiderosis, which plays a considerable function in thalassaemia patients before and role in early mortality, can be prevented or after treatment with high-dose deferoxam- postponed by iron-chelating agents which ine. (who.int)
- The study included 15 thalassaemia allow the formation of more excretable patients aged 15-25 years who had some iron complexes [1,3]. (who.int)
- Thalassaemia patients attending King Abdulaziz University Hospital were sequentially approached for en- rolment. (who.int)
- Thalassaemia is an inherited haemolytic anaemia associated with chelating agents ( 15 ). (who.int)
Oxides2
- Ingredients indicated by CI-codes are exclusively natural pigments like iron oxides. (dermaviduals.de)
- There, iron oxides adsorb phosphates and other metals. (ukaps.org)
Therapy2
- Iron-chelating therapy. (koreamed.org)
- The diagnosis was 'mild iron deficiency anemia,' and iron therapy was prescribed. (cdc.gov)
Anemia2
- Ventrixylâ„¢ FE is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. (drugs.com)
- Name three causes of iron-deficiency anemia. (studystack.com)
Hemoglobin2
- Does not affect iron in the cytochromes or hemoglobin. (medscape.com)
- Liver, hormonal (endocrine) and heart problems become increasingly important as patients grow older, due to the stress of low hemoglobin counts and high iron content. (childrenshospital.org)
Medication1
- Liquid iron may stain teeth: Give medication with a syringe, straw or dropper. (studystack.com)
Chelation1
- Oral iron chelation agent that is demonstrated to reduce the liver iron concentration in adults and children who receive repeated RBC transfusions. (medscape.com)
Metals4
- That said, some species are unable to get iron (and other transition metals) in an alkaline environment full of bicarbonates. (ukaps.org)
- The content of iron and other metals is below detection. (ukaps.org)
- antioxidants have been reported radical scavenging, to prevent oxidative damage caused by free radical , interfere with the oxidation process by reacting with free radical s, chelating, catalytic metals and also by acting as oxygen scavengers. (scialert.net)
- The idea being that when the chelating or metal binding agent is introduced into the body, it would have a particular attraction or affinity to those toxic metals that otherwise may remain trapped in your body for years and possibility most of your life. (antiaging-systems.com)
Efficacy1
- Objectives the aim of this study was to assess the safety and efficacy of adding a novel iron-chelating agent, CP94 (1,2-diethyl-3-hydroxypyridin-4-one hydrochloride), to topical ALA, to temporarily increase the accumulation of the photosensitizer in the tumour. (exeter.ac.uk)
Myocardial2
- MRI assessment of myocardial iron loading with the use of gradient echo T2* measurements has reliable reproducibility and has been validated in multiple centers. (medscape.com)
- All 6 subjects with elevated myocardial iron showed improvement in MRI T2* (p=0.031). (nih.gov)
Infusion1
- The administration of DFX during infusion of DFO further lowered NTBI (-0.28±0.08 μM, p=0.004) and labile plasma iron (LPI, -0.03±0.01 μM, p=0.006). (nih.gov)
Substance1
- Steam iron cleaner is a substance used to clean steam irons. (medlineplus.gov)
Systemic iron1
- Regulation of systemic iron homeostasis: how the body responds to changes in iron demand. (medscape.com)
Treatment4
- How well someone does depends on how much steam iron cleaner they swallowed and how quickly they receive treatment. (medlineplus.gov)
- Iron chelating agents are often used for treatment but, at present, most of these have a narrow scope of application, obvious side effects, and other disadvantages. (greenmedinfo.com)
- Also for the treatment of conditions in which iron deficiency and vitamin C deficiency occur together, along with a deficient intake or increased need for B-Complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence. (drugs.com)
- The treatment should be performed under acidic conditions to avoid the precipitation of iron at high pH values. (hindawi.com)
Metal1
- Based on form, the overall agriculture micronutrients market is segmented within non-chelated and chelated forms, wherein the Chelated Micronutrients are formed by combining a chelating agent with metal through coordinate bonding. (prlog.org)
Organic2
- Living bacteria as well as dead organic matter make iron perpetually transforming, and plants can get it through their roots. (ukaps.org)
- Organic chemicals that form two or more coordination links with an iron ion. (bvsalud.org)
Copper2
- Iron-gall ink and green copper pigments. (uib.no)
- Lotus flower being enriched with certain minerals like iron, copper and vitamins like vitamin C and vitamin B aids to strengthen the scalp when use in form of oil or extract. (dermaessentia.com)
Widely1
- Successful development of a more widely accessible and acceptable, oral iron-chelating agent could solve the problem of compliance in countries with limited resources, where morbidity and mortality are mainly caused by limited access to appropriate medical care. (who.int)
Patient's1
- During the second stage, which may continue for up to 24 hours following ingestion, the patient's GI symptoms may resolve, providing a false sense of security despite toxic amounts of iron absorption. (mhmedical.com)
Absorption of iron1
- Although the absorption of iron is best when taken between meals, giving Ventrixyl â„¢ FE after meals may control occasional gastrointestinal disturbances. (drugs.com)
Severe2
- Severe hemorrhage, inability to absorb iron, excessive growth requirements, inadequate diet, and GI bleeding r/t lactose intolerance. (studystack.com)
- Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. (nih.gov)
Oral iron chela1
- CONCLUSIONS: DFP is an effective and fairly well tolerated oral iron chelating agent. (who.int)
Excess1
- When the body cannot remove iron effectively, the excess iron can cause damage. (europa.eu)
Accidental2
Gastric1
- The fifth stage, which occurs 4 to 6 weeks after ingestion, reflects the corrosive affects of iron on the pyloric mucosa and may cause gastric outlet obstruction. (mhmedical.com)
Excretion1
- Chelating agents help reduce iron levels in the body by promoting the excretion of chelated iron. (medscape.com)
Mechanism1
- It functions via Iron Chelator mechanism of action. (globaldata.com)
Dysfunction1
- The starting dose in individuals without iron-induced cardiac dysfunction is 30 mg/kg daily infused over 8 to 12 hours, five days per week. (medscape.com)
Toxic2
Patients2
Symptoms1
- Below are symptoms of steam iron cleaner poisoning in different parts of the body. (medlineplus.gov)
20211
- In: En-Compass-Ing Culture(s): Beyond East/West and South/North, 10-12 March 2021, Helsinki/ online. (arts.ac.uk)
Hepatic1
- [ 60 ] Quantitative R2* MRI using the transverse magnetic relaxation rate is useful for the measurement of hepatic iron content at facilities with experienced personnel and the proper equipment.58 Liver iron content estimated by MRI was found to be strongly correlated to that measured by liver biopsy in many studies. (medscape.com)
High1
- Volatility of both agents is significant at high ambient temperatures. (cdc.gov)